ArticleBMC cancer2021

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.

Honglei Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.